MRNA Historical PE Ratio image   This MRNA PE ratio history page last updated 8/5/2022
MRNA Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/3/2022
186.495.2420.968.9
Q1 2022
5/4/2022
155.058.5834.324.5
Q4 2021
2/24/2022
156.2311.2945.163.5
Q3 2021
11/4/2021
284.027.7030.809.2
Q2 2021
8/5/2021
416.266.4625.8416.1
Q1 2021
5/6/2021
160.502.8411.3614.1
Q4 2020
2/25/2021
148.38-0.69-2.76NA
Q3 2020
10/29/2020
71.28-0.59-2.36NA
Q2 2020
8/5/2020
75.80-0.31-1.24NA
Q1 2020
5/7/2020
53.19-0.35-1.40NA
Q4 2019
2/26/2020
29.16-0.37-1.48NA
Q3 2019
11/6/2019
16.13-0.37-1.48NA
Q2 2019
8/7/2019
12.85-0.41-1.64NA
Q1 2019
5/8/2019
23.54-0.40-1.60NA
Q4 2018
3/6/2019
20.65-0.43-1.72NA
MRNA PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/3/2022
186.495.2432.815.7
Q1 2022
5/4/2022
155.058.5834.034.6
Q4 2021
2/24/2022
156.2311.2928.295.5
Q3 2021
11/4/2021
284.027.7016.3117.4
Q2 2021
8/5/2021
416.266.468.0251.9
Q1 2021
5/6/2021
160.502.841.25128.4
Q4 2020
2/25/2021
148.38-0.69-1.94NA
Q3 2020
10/29/2020
71.28-0.59-1.62NA
Q2 2020
8/5/2020
75.80-0.31-1.40NA
Q1 2020
5/7/2020
53.19-0.35-1.50NA
Q4 2019
2/26/2020
29.16-0.37-1.55NA
Q3 2019
11/6/2019
16.13-0.37-1.61NA
Q2 2019
8/7/2019
12.85-0.41NANA
Q1 2019
5/8/2019
23.54-0.40NANA
Q4 2018
3/6/2019
20.65-0.43NANA
Quotes delayed 20 minutes

Email EnvelopeFree MRNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Moderna (MRNA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

MRNS PE Ratio History
MRSN PE Ratio History
MRTX PE Ratio History
MRVI PE Ratio History
MSON PE Ratio History
MTCR PE Ratio History
MTEM PE Ratio History
MXCT PE Ratio History
MYGN PE Ratio History
MYMD PE Ratio History
How should the MRNA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Moderna. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this MRNA Historical PE Ratio page.

What is the average historical PE for MRNA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The MRNA historical PE ratio using the annualized quarterly earnings method works out to 9.4.

What is the average historical PE for MRNA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The MRNA historical PE ratio using the TTM earnings method works out to 35.6.

What is the average historical PE for MRNA based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The MRNA historical PE ratio using the annualized median TTM earnings method works out to 32.56.

On this page we presented the MRNA Historical PE Ratio information for Moderna' stock. The average MRNA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 9.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MRNA historical PE based on this TTM earnings result method is 35.6. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this MRNA historical PE result, against the recent PE: when this page was posted on 8/4/2022, the most recent closing price for MRNA had been 194.18, and the most recent quarterly earnings result, annualized, was 20.96. Meanwhile, the most recent TTM earnings summed to 32.81. From these numbers, we calculate the recent MRNA PE on 8/4/2022 based on annualized quarterly EPS was 9.3. Based on MRNA's history, that recent PE is low relative to the historical average, with the recent PE 1.1% lower than the historical average PE across our data set for Moderna. Looking at the recent MRNA PE on 8/4/2022 based on TTM EPS, we calculate the ratio at 5.9. Based on MRNA's history, that recent PE is low relative to the historical average, with the recent PE 83.4% lower than the average PE across our Moderna data set with TTM EPS used in the calculation at each period.

Another interesting MRNA historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for MRNA, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for MRNA, we start with the past four EPS numbers and we first sort them from lowest to highest: 5.24, 7.70, 8.58, and 11.29. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 7.70 and 8.58 — which gives us the median of 8.14. Basically the way to think about this 8.14 number is this: for the trailing four earnings reports, 8.14 marks the "middle ground" number where MRNA has reported a value higher than 8.14 half the time, and has reported a value lower than 8.14 half the time. Annualizing that median value then gets us to 32.56/share, which we use as the denominator in our next PE calculation. With 194.18 as the numerator (as of 8/4/2022), the calculation is then 194.18 / 32.56 = 6.0 as the MRNA PE ratio as of 8/4/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on MRNA or any other given stock, valuation analysis for MRNA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Moderna PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MRNA. Thanks for visiting, and the next time you need to research MRNA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding GACQ, Funds Holding KRUS, Funds Holding IPLY.

 

MRNA Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.